Global Blood Therapeutics Leaves ASH With Momentum Behind Voxelotor In Sickle Cell Disease

 
• By Jessica Merrill
Anemia, sickle cell and normal red blood cell, 3d Illustration.

More from Clinical Trials

More from R&D